Who
Robyn Hunter
Director
Company insider
Files Form 4 as: Director, Tenax Therapeutics; Chief Financial Officer, Fortress Biotech.
In numbers
- Trades disclosed
- 9
- Buys
- 1
- Sells
- 3
- Bought
- $2,527
- Sold
- $239K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 23 Nov 2018
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 10 Dec 2024filed 12 Dec 2024 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 9 Jun 2022filed 10 Jun 2022 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 21 Sep 2021filed 29 Apr 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Sold | $89K28,292 at $3.13 | filing |
| 22 Sep 2020filed 25 Sep 2020 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Sold | $125K28,450 at $4.38 | filing |
| 3 Jun 2019filed 31 Dec 2019 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $2,5272,297 at $1.10 | filing |
| 23 Nov 2018filed 30 Nov 2018 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Sold | $26K20,370 at $1.29 | filing |
News
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 17 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Robyn Hunter; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.